DASATINIB MYLAN
20MG TBL FLM 56X1
| SÚKL code | 0251057 |
|---|---|
| Name of the product | DASATINIB MYLAN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | DASATINIB MYLAN |
| Supplement | 20MG TBL FLM 56X1 |
| Strenght | 20MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 56X1 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | |
| Legal status | na lékařský předpis |
| Active substance | DASATINIB (DASATINIBUM) |
| ATC group | L01EA02 |
| ATC group name | DASATINIB |
Marketing authorisation information
| Registration Number | 44/ 451/18-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2022 |
| MA Holder | Mylan Ireland Limited, Dublin |
| MA Holder country | IRSKO |
| Actual MA holder | VIATRIS LIMITED, Dublin |
| Actual MA holder country | IRSKO |
cz